Amphastar Pharmaceuticals (AMPH) Reports Next Week: Wall Street Expects Earnings Growth

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Amphastar Pharmaceuticals, with a focus on how actual results compare to estimates impacting stock price [1] Group 1: Earnings Expectations - Amphastar is expected to report quarterly earnings of $0.77 per share, reflecting a year-over-year increase of +24.2% [2] - Revenues are projected to be $171.6 million, which is a 22.6% increase from the same quarter last year [2] Group 2: Estimate Revisions - The consensus EPS estimate has been revised 3.48% lower in the last 30 days, indicating a reassessment by analysts [2] - The direction of estimate revisions may not always reflect in the aggregate change [2] Group 3: Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for Amphastar is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +1.68% [5] - A positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [4] Group 4: Historical Performance - Amphastar has consistently beaten consensus EPS estimates, achieving a surprise of +1.15% in the last reported quarter [7] - The company has surpassed consensus EPS estimates in all of the last four quarters [7] Group 5: Investment Considerations - While an earnings beat may not solely dictate stock movement, betting on stocks expected to exceed earnings expectations can enhance success odds [8] - Amphastar is viewed as a compelling candidate for an earnings beat, but investors should consider other influencing factors [8]